Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial

Circulation. 2024 Jul 2;150(1):82-85. doi: 10.1161/CIRCULATIONAHA.123.066709. Epub 2024 Jul 1.
No abstract available

Keywords: COVID-19; anticoagulants; therapeutics.

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • COVID-19 Drug Treatment*
  • COVID-19*
  • Factor Xa Inhibitors* / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Outpatients*
  • Pyrazoles* / therapeutic use
  • Pyridones* / therapeutic use
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • apixaban
  • Pyridones
  • Pyrazoles
  • Factor Xa Inhibitors